On March 26, 2020, the US Trade Representative (USTR) published in the Federal Register a noticethat announces USTR’s determination to grant certain exclusion requests to the $200 Bn action against certain products from China, as specified in the Annex to the notice, and corrects technical errors in previously announced exclusions. The exclusions are reflected in one 10-digit HTSUS subheading, which covers one exclusion request, and 176 specially prepared product descriptions, which cover 202 separate exclusion…

On March 25, 2020, the US Trade Representative (USTR) posted an advance copy of a notice to be published in the Federal Register that announces USTR’s determination to grant certain exclusion requests to the $300 Bn action against certain products from China, as specified in the Annex to the notice. : These product exclusions will apply as of September 1, 2019, the effective date of List 1 of the $300 billion action, and will extend…

On March 25, 2019, the US Trade Representative (USTR) will publish in the Federal Register a notice [Docket No. USTR-2020-0014] requesting public comments on possible further modifications to remove duties from additional medical-care products needed to address the COVID-19 outbreak. Section 301 duties have been imposed in four tranches. For each tranche, USTR established a process by which US stakeholders could request exclusion of particular products classified within an eight-digit Harmonized Tariff Schedule of the…

On March 19, 2020, the Office of the United States Trade Representative (USTR) published in the Federal Register a notice announcing the USTR’s determination to grant extensions to certain exclusion requests from the $34 Bn action (Tranche 1). USTR initiated the exclusion process in July 2018 and, to date, has granted ten sets of exclusions. The second set of exclusions was published in March 2019 and will expire in March 2020. On December 30, 2019,…